What is Jeuveau™?
The goal of aging gracefully just keeps getting easier to obtain. The development of neurotoxins and other injectables are now routinely used to fight the effects of gravity and aging. Jeuveau™ is a recent advancement that is sitting alongside Botox® as an option for facial rejuvenation.
The Jeuveau™ injectable is made using the same 900 kDa protein that is found in Botox®, classifying it as a neuromodulator. As such, the FDA-approved cosmetic drug smoothes lines and wrinkles by relaxing muscle contractions. Jeuveau™ can also be used preventatively to prevent new lines from developing.
benefits of Jeuveau™
Aside from being a convenient anti-aging treatment, patients appreciate the fact that the active ingredient in Jeuveau™, 900 kDa purified botulinum toxin formula type A, has been proven safe and effective through its use in Botox® Cosmetic. This protein has been in use since the late 1980s and has very few risks associated with it. For Jeuveau™, no adverse reactions have been reported to date.
To gain FDA approval, the makers of Jeuveau™ put this drug through two clinical trials that involved double-blind placebo studies. In each trial, Jeuveau™ demonstrated high efficacy in meeting the primary goal of reducing glabellar lines in thirty days. In one study, 65.7% of patients achieved successful results. That statistic reached 70.4% in the second study.
Efficacy is one of the leading benefits of Jeuveau™ treatment, with safety also being high priority. Additionally, this treatment was developed solely for cosmetic use and is generally available at a lower cost than other neuromodulator treatments.
Jeuveau™ Before & After
Who is a candidate for Jeuveau™?
Anyone who is a good candidate for Botox® and other neuromodulators is a good candidate for Jeuveau™ treatment. Having undergone Botox or other treatments does not exclude a person from getting Jeuveau™ unless an adverse reaction to the neurotoxin has occurred in the past.
People with an allergy to botulinum toxin type A or certain neuromuscular conditions such as ALS should not get Jeuveau™. This drug is also not approved for women who are pregnant or nursing. Treatment should not be conducted in an area where the skin is inflamed.
Patients interested in significant facial rejuvenation can get Jeuveau™ in conjunction with other treatments such as dermal fillers.
Jeuveau™ Vs. Botox®
Being derived from the same protein, Jeuveau™ is nearly the same as Botox®. Each drug works on the same principle of blocking nerve transmissions in muscles to smooth creases on the face. The onset of results is very similar, as is the longevity of smoothness.
While Jeuveau™ is the NewTox compared to well-known Botox®, this new drug is expected to establish strong loyalty among providers and consumers due to its price point. In addition to cost-effectiveness, Jeuveau™ also performed very well in clinical trials. So, while not yet the household name that Botox® is, Jeuveau™ is quickly proving itself in clinical practice. The drug is currently achieving similar results to Botox®, without concerning side effects.
What should I expect from results of Jeuveau™?
How long will the results of Jeuveau™ last?
side effects of Jeuveau™
Like other injectable treatments, Jeuveau™ achieves good results with minimal downtime, if any. Patients can resume normal activities right away but may wish to avoid lying down for a few hours or, conversely, immediately engaging in strenuous physical activity.
The most common side effects noted with Jeuveau™ are similar to other injectables. These include swelling, pinpoint redness and minor bruising. Some patients may feel slight tenderness or may develop a headache that decreases within a few hours. The likelihood of this last side effect is measured at only around 10 percent.
Similar to other neuromodulators, there is a rare risk of a patient having more intense reactions to Jeuveau™ treatment. Side effects such as eyelid drooping, difficulty breathing, strained speech, or difficulty swallowing may indicate an allergic reaction and should be treated promptly.